All lobbying filings

SL Strategies, LLC

SL Strategies, LLC filed a Q4 report for Partner Therapeutics on January 20, 2026, reporting $45,000 in lobbying income.

Lobbying for Partner Therapeutics · biotechnology company

As filed: SL STRATEGIES, LLC for PARTNER THERAPEUTICS.

All filings by SL Strategies, LLC · Everything Partner Therapeutics has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$45,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Lobbyists on this filing 1

MARY MOODY JOHNSON

Previously held: U.S. Senate Committee on Health, Education, Labor and Pensions

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to rad/nuc preparedness and response; Pandemic All-Hazards Preparedness and Response

Budget/Appropriations

Fiscal Year 2026 HHS appropriations for rad/nuc preparedness and response, specifically within BARDA and the Strategic National Stockpile.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.